Micardis

unable to take ACE inhibitors, prophylaxis of cardiovascular event, Congestive Heart Failure + 5 more
Treatment
6 FDA approvals
20 Active Studies for Micardis

What is Micardis

TelmisartanThe Generic name of this drug
Treatment SummaryTelmisartan is a medication used to lower high blood pressure. It works by blocking the action of angiotensin II, a hormone that causes blood vessels to narrow. It is classified as an angiotensin II receptor blocker (ARB). Recent studies suggest that telmisartan may also help improve metabolism and have other beneficial effects.
Micardis HCTis the brand name
image of different drug pills on a surface
Micardis Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Micardis HCT
Telmisartan
2000
182

Approved as Treatment by the FDA

Telmisartan, also known as Micardis HCT, is approved by the FDA for 6 uses including Hypertension and unable to take ACE inhibitors .
Hypertension
Used to treat blood pressure inadequately controlled with monotherapy in combination with Amlodipine
unable to take ACE inhibitors
prophylaxis of cardiovascular event
Cardiovascular Events
Hypertensive disease
Helps manage High Blood Pressure (Hypertension)
no initial therapy
Used to treat no initial therapy in combination with Amlodipine

Effectiveness

How Micardis Affects PatientsTelmisartan is a drug taken orally that stops angiotensin II, a hormone that increases blood pressure and affects the balance of water and sodium in the body, from working. It has the strongest connection to the angiotensin II receptor than other similar drugs, and has been found to have properties that can help with glucose and lipid metabolism, and reduce inflammation. Telmisartan works by preventing angiotensin II from causing the body to narrow blood vessels, release aldosterone, and increase the amount of sodium in the blood.
How Micardis works in the bodyTelmisartan blocks the action of angiotensin II, a hormone that causes blood vessels to constrict. This decreases the resistance of blood vessels, improving blood flow. Telmisartan does not affect other hormones or ion channels, but it may activate a receptor known as PPARγ. This can improve metabolism, helping to control diabetes without causing side effects.

When to interrupt dosage

The magnitude of Micardis is contingent upon the diagnosed disorder, such as an inability to take ACE inhibitors, Hypertensive disease and Diabetic Nephropathy. The amount of dosage is contingent upon the mode of delivery (e.g. Tablet - Oral or Tablet, multilayer) featured in the below table.
Condition
Dosage
Administration
unable to take ACE inhibitors
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral
prophylaxis of cardiovascular event
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral
Congestive Heart Failure
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral
Hypertensive disease
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral
Diabetic Nephropathies
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral
Cardiovascular Events
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral
no initial therapy
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral
Hypertension
, 40.0 mg, 80.0 mg, 20.0 mg
, Oral, Tablet, Tablet - Oral, Tablet, multilayer, Tablet, multilayer - Oral

Warnings

Micardis Contraindications
Condition
Risk Level
Notes
Type 2 Diabetes
Do Not Combine
There are 20 known major drug interactions with Micardis.
Common Micardis Drug Interactions
Drug Name
Risk Level
Description
Acenocoumarol
Major
The metabolism of Acenocoumarol can be decreased when combined with Telmisartan.
Amifostine
Major
Telmisartan may increase the hypotensive activities of Amifostine.
Axitinib
Major
The metabolism of Axitinib can be decreased when combined with Telmisartan.
Clomipramine
Major
The metabolism of Clomipramine can be decreased when combined with Telmisartan.
Cyclophosphamide
Major
The metabolism of Cyclophosphamide can be decreased when combined with Telmisartan.
Micardis Toxicity & Overdose RiskThe lowest toxic dose of telmisartan in rats is 150-200 mg/kg in males and 200 to 250 mg/kg in females. There is no evidence of toxicity in rats or dogs when given 2000 mg/kg. Limited data is available on overdosage in humans, however likely symptoms include low blood pressure, dizziness, fast heartbeat, and slow heartbeat from overstimulation of the nervous system.
image of a doctor in a lab doing drug, clinical research

Micardis Novel Uses: Which Conditions Have a Clinical Trial Featuring Micardis?

328 active studies are in progress to gauge the potential of Micardis to improve blood pressure inadequately controlled with monotherapy, those unable to take ACE inhibitors and those with no initial therapy.
Condition
Clinical Trials
Trial Phases
no initial therapy
0 Actively Recruiting
Congestive Heart Failure
184 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4, Phase 3, Early Phase 1
unable to take ACE inhibitors
0 Actively Recruiting
Cardiovascular Events
4 Actively Recruiting
Not Applicable
Hypertension
0 Actively Recruiting
prophylaxis of cardiovascular event
0 Actively Recruiting
Diabetic Nephropathies
0 Actively Recruiting
Hypertensive disease
27 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 3

Micardis Reviews: What are patients saying about Micardis?

5Patient Review
11/7/2013
Micardis for High Blood Pressure
While this treatment is effective, it's not affordable for those on a fixed income. Additionally, the packaging is difficult to open and the tablet itself is quite sticky.
5Patient Review
5/11/2014
Micardis for High Blood Pressure
Even though my arms are still heavy and my back pain is bad, this treatment has helped me a lot.
4.7Patient Review
3/18/2017
Micardis for High Blood Pressure
I've been on this medication for four and a half years now, taking one eighty-milligram pill each day. It works well for me; my blood pressure usually runs between 130/120 and 80. The only downside is that I get tired more easily, but that's a fair tradeoff compared to alternatives like heart transplants (which my brother had to go through). If you're considering this medication, Boehringer Ingelheim offers a reduced price program that brings the monthly cost down to $35.35 per month.
4Patient Review
1/6/2014
Micardis for High Blood Pressure
I've been on this medication for a month to help with my blood pressure. Although it hasn't lowered my BP as much as I'd hoped, I have experienced other benefits like no muscle aches (though I take potassium pills too) and less fatigue. The only downside is that I've had a hacking cough, but based on what others have said, this may be a side effect of the medication.
3.7Patient Review
7/4/2014
Micardis for High Blood Pressure
My blood pressure has been spiking since my doctor told me to double my medication. I'm not sure if it's the heat or what, but it's been really frustrating.
3.7Patient Review
10/17/2013
Micardis for High Blood Pressure
3.7Patient Review
1/7/2014
Micardis for High Blood Pressure
The packaging of the individual tablets can be difficult to open.
3.3Patient Review
4/7/2014
Micardis for High Blood Pressure
I'm 59 years old and I was on Marcardis for about a month. I experienced almost half of the listed side effects, which were becoming increasingly severe. My blood pressure dropped to an alarmingly low level and my energy levels bottomed out, so I stopped taking the medication.
3.3Patient Review
5/23/2015
Micardis for High Blood Pressure
I've been taking Micardis for two months now, and I definitely prefer it to Nifedipine. I didn't have any of the side effects with Micardis that I did with Nifedipine (sleeplessness, trouble breathing), and Lisinopril was good too but I couldn't get it where I am. The only downside to Micardis is that the packaging is a pain to open.
3.3Patient Review
5/15/2014
Micardis for High Blood Pressure
No issues thus far, five days in.
3Patient Review
6/24/2014
Micardis for High Blood Pressure
I've been on this medication for over a decade now. It's effective and I don't really notice any negative side effects.
2.7Patient Review
12/25/2018
Micardis for High Blood Pressure
I was prescribed this for high blood pressure, but it only made my heart rate increase. I've also gained a lot of weight and become more clumsy over the past year. Despite increasing the dosage and adding amlodipine, my blood pressure hasn't changed much. I'm getting injured more frequently from falls, so I've decided to stop taking the medication.
2.7Patient Review
11/15/2018
Micardis for High Blood Pressure
This blister pack was very difficult to open, even compared to other similar products I've used in the past.
1.7Patient Review
3/31/2014
Micardis for High Blood Pressure
I tried this treatment for a month and while it did lower my blood pressure, the side effects were intolerable. I experienced dizziness, aches in my neck and shoulders, leg cramps, and eye strain. I've since switched to a different medication.
1.3Patient Review
1/1/2014
Micardis for High Blood Pressure
I've been on Micardis for over a decade now, and it's kept my blood pressure at a healthy level. I'm able to exercise regularly, and my heart rate is good. I also take Norvasc in the morning and evening.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about micardis

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the side effect of Micardis?

"If you experience any of the following, call your doctor: swelling in your feet or ankles; rapid weight gain; unusual pain or tightness in your lower body; a skin ulcer; or a high potassium level. Symptoms of a high potassium level include nausea, weakness, tingly feeling, chest pain, irregular heartbeats, and loss of movement."

Answered by AI

Is Micardis a good blood pressure medicine?

"Telmisartan is an effective blood pressure-lowering medication that has beneficial effects on the heart and kidneys."

Answered by AI

What is the drug Micardis used for?

"This medication is used to lower high blood pressure in order to prevent strokes, heart attacks, and kidney problems. Telmisartan belongs to a class of drugs known as angiotensin receptor blockers (ARBs)."

Answered by AI

Which is better losartan or Micardis?

"Cozaar lowers blood pressure while simultaneously protecting kidney function, and has far fewer side effects than ACE inhibitors. Micardis lowers the risk of heart attack and stroke, and is similar to ACE inhibitors, but does not come with the same side effects, like coughing."

Answered by AI

Clinical Trials for Micardis

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL
This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.
Waitlist Available
Has No Placebo
U Health (+1 Sites)Ziad Zoghby, M.D., M.B.A.Biobeat Technologies Ltd.
Have you considered Micardis clinical trials? We made a collection of clinical trials featuring Micardis, we think they might fit your search criteria.Go to Trials
Image of Los Angeles General Medical Center in Los Angeles, United States.

Supportive Management for Heart Failure and Methamphetamine Addiction

18+
All Sexes
Los Angeles, CA
Heart failure (HF) affects over 6 million people in the US and is a major cause of both hospital admissions and death. HF has many causes and contributing factors. One of the most aggressive forms of HF is associated with methamphetamine abuse, which has become its own epidemic in the US over the past twenty years. People who use methamphetamine tend to develop HF at a much younger age, with more severe disease and more serious consequences. A recent analysis using nationwide data, methamphetamine use doubled the risk of death or hospitalizations compared to non-users in patients with HF. Thus, methamphetamine users with HF represent a very high-risk group of patients from a healthcare perspective. HF may be reversible in some patients who use methamphetamine if patients can achieve 1) abstain from further methamphetamine use and 2) consistently take all the medications that can improve HF. These two goals are very difficult to achieve in practice, as the care of both methamphetamine addiction and HF requires specialized medical expertise and intensive regular follow up of patients. In general, achievement of one goal is not possible without the other. Patients who use methamphetamine have poor adherence to medical follow-up and therapies, and abstinence from methamphetamine is difficult to maintain. This is further complicated because the current model of HF care does not incorporate treatment for methamphetamine use. The current study proposes to launch a multidisciplinary clinic that treats both HF and methamphetamine use disorder at the same time. The HF care will be led by a cardiologist while the methamphetamine use treatment will be led by a psychiatric clinical pharmacist trained in addiction medicine. State-of-the-art HF care will include optimization of four pillar HF medications. Methamphetamine use treatment will include counseling and incentivized abstinence known as contingency management (CM). The investigators will manage the patients in the clinic for 6 months total. The investigators are interested in demonstrating that this integrated clinic model will result in improved delivery of care for these patients by reporting the rates of successful abstinence from methamphetamine, improved optimization of the four HF medications, and enhanced patient reported quality of life over the 6 months of follow up. The investigators will also collect data on the costs associated with providing this level of care and estimate a range of potential cost-savings.
Waitlist Available
Has No Placebo
Los Angeles General Medical Center (+1 Sites)Tien Ng, PharmD
Have you considered Micardis clinical trials? We made a collection of clinical trials featuring Micardis, we think they might fit your search criteria.Go to Trials
Image of Cleveland Clinic Avon Hospital in Avon, United States.

Wake and Weigh for Heart Failure

18+
All Sexes
Avon, OH
Ongoing self-care for heart failure is essential to avoid complications and hospitalization. Supportive strategies are needed; however, patients with heart failure may find many interventions complicated and overwhelming. The purpose of this pilot study is to implement a simple weight tracking tool (Wake and Weigh) to affect self-care and quality of life in a population of older adults with heart failure. This will be a randomized controlled pilot trial to test the methods to be used in a larger randomized controlled trial. The Self-care in Heart Failure Index and Kansas City Cardiomyopathy Questionnaire surveys will be given at admission and four weeks after discharge. The Wake and Weigh tool is designed to help patients track weight in the hospital and following discharge. Feasibility endpoints will be summarized descriptively.
Recruiting
Has No Placebo
Cleveland Clinic Avon Hospital
Image of Baystate Medical Center in Springfield, United States.

Consent Approaches for Heart Disease Rehabilitation

18+
All Sexes
Springfield, MA
Cardiac Rehabilitation is a lifestyle and exercise program for patients with heart disease. Cardiac Rehabilitation is strongly recommended in guidelines, but only 30% of eligible patients attend. New strategies are needed to help more patients attend cardiac rehabilitation. In this study, the investigators will see if using an $50 incentive, case management, text messages, and physical activity coaching combined into a single intervention will help more patients attend cardiac rehabilitation. In preparation for a larger trial, patients will also be randomly assigned to four different ways of seeking their permission to be in a research study. The investigators will see if these approaches affect how many people participate in the research project. The two main goals of this study is to understand: 1. If the consent approach type impacts participation rates in the research study 2. If the multi-component intervention (case management, financial incentives, text messages, and physical activity coaching) improves cardiac rehabilitation participation within 3 months.
Waitlist Available
Has No Placebo
Baystate Medical CenterQuinn R Pack, MD, MSc
Have you considered Micardis clinical trials? We made a collection of clinical trials featuring Micardis, we think they might fit your search criteria.Go to Trials
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security